0
Scientific Articles   |    
Partial Epiphyseal Preservation and Intercalary Allograft Reconstruction in High-Grade Metaphyseal Osteosarcoma of the Knee
D. Luis Muscolo, MD1; Miguel A. Ayerza, MD1; Luis A. Aponte-Tinao, MD1; Maximiliano Ranalletta, MD1
1 Institute of Orthopedics “Carlos E. Ottolenghi,” Italian Hospital of Buenos Aires, Potosí 4215, (1199) Buenos Aires, Argentina. E-mail address for D.L. Muscolo: luis.muscolo@hospitalitaliano.org.ar
View Disclosures and Other Information
The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.
Read in part at the Annual Meeting of the American Academy of Orthopaedic Surgeons, San Francisco, California, March 11, 2004.
Investigation performed at the Institute of Orthopedics "Carlos E. Ottolenghi," Italian Hospital of Buenos Aires, Buenos Aires, Argentina

The Journal of Bone and Joint Surgery, Incorporated
J Bone Joint Surg Am, 2004 Dec 01;86(12):2686-2693
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Background: The purpose of this study was to analyze a series of patients with a high-grade metaphyseal osteosarcoma of the knee who had been treated with a transepiphyseal resection, with preservation of the distal femoral and the proximal tibial (articular) portions of the epiphysis, and an intercalary allograft reconstruction.

Methods: The cases of thirteen patients with a high-grade metaphyseal osteosarcoma around the knee who had transepiphyseal resection and reconstruction with an intercalary allograft were retrospectively reviewed at a mean of sixty-three months. Complications, disease-free survival of the patient, final preservation of the limb and epiphysis, and functional results according to the Musculoskeletal Tumor Society scoring system were documented at the time of the latest follow-up.

Results: At the final follow-up examination, eleven of the thirteen patients continued to be disease-free. One patient died of bone and pulmonary metastases with no evidence of local recurrence, and the remaining patient had no evidence of disease after resection of a local recurrence of the tumor in the soft tissues. No patient had a local recurrence in the remaining epiphysis. Seven patients had complications that included a fracture (three patients), diaphyseal nonunion (two), deep infection (one), and a local recurrence in the soft tissues (one). The allograft was removed in only four of these patients. At the latest follow-up examination, twelve patients were alive with preserved limbs. In one patient, the epiphysis, which originally had been preserved, was resected because of a metaphyseal fracture, and the limb was reconstructed with an osteoarticular allograft. The patients with a preserved epiphysis had an average functional score of 27 points (maximum, 30 points).

Conclusions: Preservation of the epiphysis in high-grade metaphyseal osteosarcoma at the knee is an alternative in carefully selected patients. Crucial factors needed to obtain local tumor control and achieve an acceptable functional result are a positive response to chemotherapy, accurate preoperative assessment of tumor extension to the epiphysis, and appropriate fixation techniques for intercalary allografts.

Level of Evidence: Therapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.

Figures in this Article
    Sign In to Your Personal ProfileSign In To Access Full Content
    Not a Subscriber?
    Get online access for 30 days for $35
    New to JBJS?
    Sign up for a full subscription to both the print and online editions
    Register for a FREE limited account to get full access to all CME activities, to comment on public articles, or to sign up for alerts.
    Register for a FREE limited account to get full access to all CME activities
    Have a subscription to the print edition?
    Current subscribers to The Journal of Bone & Joint Surgery in either the print or quarterly DVD formats receive free online access to JBJS.org.
    Forgot your password?
    Enter your username and email address. We'll send you a reminder to the email address on record.

     
    Forgot your username or need assistance? Please contact customer service at subs@jbjs.org. If your access is provided
    by your institution, please contact you librarian or administrator for username and password information. Institutional
    administrators, to reset your institution's master username or password, please contact subs@jbjs.org

    References

    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    D. Luis Muscolo, M.D.
    Posted on January 21, 2005
    Dr Muscolo and colleagues respond to Dr. Erler
    Institute of Orthopedics, "Carlos E. Ottolenghi," Italian Hospital of Buenos Aires, Argentina

    To the Editor:

    We wish to thank Dr. Erler for his interest in our paper. His main concerns seem to be durability of reconstructions and allograft complications. We, as most orthopaedic oncology surgeons, share those concerns in relation to the durability of all reconstructive procedures now available, since we are treating very young patients many of them with several decades of life expectancy.

    In relation to complications of intercalary allograft recosntructions, this crucial issue was extensively covered in our manuscript. Table I includes the total number of allograft complications. In the Results section, we reported, “Of the 13 patients in the study, only six healed and had no complications. Surgical procedures were performed for complications in seven patients, which included three fractures, two diaphyseal non-unions, one deep infection, and one soft tissue local recurrence. In four of these patients the allograft was removed. All fractures were localized in the femur and were treated by reconstruction with a new allograft, two with another intercalary graft and one was converted to an osteoarticular allograft, sacrificing the originally preserved epiphysis. In both diaphyseal non- unions a single operation, in which the internal fixation was replaced and autogenous graft was added to the site, resulted in union at the host- donor junction. No non-union was associated with failure of the graft, since all healed after a reoperation. One patient developed and acute deep infection; the allograft was removed and a temporary cement spacer with antibiotics was implanted.”

    In the Discussion we stated, “Substantial reconstructive complications should be expected after these technically demanding surgical procedures. Seven patients in this series needed a second operation. Four had a reconstructive failure, defined as the necessity to excise the allograft. However, after reoperations in three patients, the osteoarticular surface was again preserved, and a second intercalary allograft was performed. In the remaining patient the epiphysis was resected and a osteoarticular allograft reconstruction was done.”

    “Our findings suggest that, although complications requiring a second operations could be expected after reconstruction, about one of six patients with a metaphyseal osteosarcoma around the knee may be treated with appropiate oncologic margins and preservation of the epiphysis of the affected bone.”

    The main purpose of our paper was to analyze, in a small series of patients, the potential preservation of the epiphysis in high grade metaphyseal osteosarcomas of the knee. There are few reconstructive alternatives now available to fill the segmental bone defect originated with this technique, and the use of intercalary allografts is one.

    Most likely in the future new procedures with very high predictibility are going to be developed. In the meantime, the use of intercalary allografts, even considering potential complications, is, in our opinion, a very acceptable procedure to reconstruct a bone defect not affecting the articular surface.

    Kaan Erler
    Posted on January 04, 2005
    On the Results of Allograft Reconstruction for Osteosarcoma
    Gulhane Military Medical Academy, Ankara, Turkey

    To the Editor:

    I am writing to express some concerns about the results reported in the recent article by Muscolo, et al(1). According to publications by Enneking and Mankin (2-11) there were many complications(the bigger the allograft, the higher the ratio of failure).

    In this paper, the authors did not report the size of allograft used for reconstruction and did not report complications related to the use of allografts although they were fixed with screws and plate and they were used in patients treated with chemotherapy(9).

    I would be grateful for the authors response about these issues.

    Sincerely,

    Kaan Erler, M.D. Assoc. Prof. Department of Orhopaedics Orthopaedic Oncology Gülhane Military Medical Academy 06018, Ankara, Turkey

    References

    1.D. Luis Muscolo, Miguel A. Ayerza, Luis A. Aponte-Tinao, and Maximiliano Ranalletta Partial Epiphyseal Preservation and Intercalary Allograft Reconstruction in High-Grade Metaphyseal Osteosarcoma of the Knee J Bone Joint Surg Am 2004; 86: 2686-2693

    2: Enneking WF, Campanacci DA. Retrieved human allografts : a clinicopathological study. J Bone Joint Surg Am. 2001 Jul;83-A(7):971-86.

    3: Wheeler DL, Haynie JL, Berrey H, Scarborough M, Enneking, WF. Biomechanical evaluation of retrieved massive allografts: preliminary results. Biomed Sci Instrum. 2001;37:251-6.

    4: Strong DM, Friedlaender GE, Tomford WW, Springfield DS, Shives TC, Burchardt H, Enneking WF, Mankin HJ. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop. 1996 May; (326):107-14.

    5: Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg Am 1991 Sep;73(8):1123-42.

    6: Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ. Allografts about the Knee in Young Patients with High- grade Sarcoma. Clin Orthop. 2004 Apr; (421):232-9.

    7: Mankin HJ. The changes in major limb reconstruction as a result of the development of allografts. Chir Organi Mov. 2003 Apr-Jun;88(2):101-13. English, Italian.

    8: Donati D, Giacomini S, Gozzi E, Salphale Y, Mercuri M, Mankin HJ, Springfield DS, Gebhardt MC. Allograft arthrodesis tratment of bone tumors: a two-center study. Clin Orthop. 2002 Jul;(400):217-24.

    9: Fox EJ, Hau MA, Gebhardt MC, Hornicek FJ, Tomford WW, Mankin, HJ. Long-term followup of proximal femoral allografts. Clin Orthop. 2002 Apr;(397):106-13.

    10: Hazan EJ, Hornicek FJ, Tomford W, Gebhardt MC, Mankin JH. The effect of adjuvant chemotherapy on on osteoarticular allografts. Clin Orthop. 2001 Apr; (385):176-81.

    11: Sorger JI, Hornicek FJ, Zavatta M, Menzner JP, Geghardt MC, Tomford WW, Mankin HJ. Allograft fractures revisited. Clin Orthop. 2001 Jan;(382):66-74.

    The Journal of Bone & Joint Surgery
    JBJS Case Connector
    Related Content
    Topic Collections
    Related Audio and Videos
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    02/04/2013
    Michigan - Wayne State University School of Medicine
    05/03/2012
    CA - UCLA Medical Center/Dept. of Ortho Surgery
    03/20/2013
    NY - Hospital for Special Surgery
    05/15/2013
    OH - University of Cincinnati